Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population
Waleed Alduaij(University of Manchester), David W. Scott, Pedro Farinha, Laura K. Hilton(BC Cancer Agency), Jeffrey W. Craig(University of British Columbia), Aixiang Jiang(Simon Fraser University), Kerry J. Savage(BC Cancer Agency), Joseph M. Connors, Laurie H. Sehn(BC Cancer Agency), Susana Ben‐Neriah(Apple (Israel)), Randy D. Gascoyne(BC Cancer Agency), Brett Collinge, Diego Villa(University of British Columbia), Christian Steidl(Spinal Cord Injury BC), Andrew J. Mungall(Canada's Michael Smith Genome Sciences Centre), Graham W. Slack(BC Cancer Agency), Ciara L. Freeman(Moffitt Cancer Center), Tomoko Miyata‐Takata(Spinal Cord Injury BC), Ryan D. Morin(Simon Fraser University), Lauren C. Chong, Merrill Boyle, Barbara Meissner, Andrew Lytle(University of British Columbia), Alina S. Gerrie(University of British Columbia)
Cited by 89
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k